Description
NAD+ UK 500mg Research Compound
NAD+ UK 500mg is supplied by SPX Labs as a research compound for legitimate laboratory research, analytical testing and scientific evaluation. The nominal presentation contains 500mg of nicotinamide adenine dinucleotide (NAD+).
Each product carries an identifiable batch reference designed to support traceability between the supplied research material and analytical documentation associated with that batch.
NAD+ UK Research Material
Nicotinamide adenine dinucleotide (NAD+) is a naturally occurring coenzyme involved in numerous cellular biochemical processes. Unlike many other materials within the SPX Labs research catalogue, NAD+ is not a peptide.
SPX Labs supplies NAD+ exclusively as a laboratory research material. It is not supplied as a medicine, supplement or therapeutic product, and SPX Labs does not provide instructions for human or veterinary administration.
Product Profile & Specifications
Product: NAD+ (Nicotinamide Adenine Dinucleotide)
Nominal quantity: 500mg
Format: Lyophilised (freeze-dried) research material
Supplier: SPX Labs
Intended use: Laboratory research, analytical testing and scientific evaluation only
Batch identification: Provided on supplied material
Documentation: Batch-specific information available where applicable
The stated 500mg quantity represents the nominal SPX Labs product presentation. Where analytical testing has been performed, experimentally reported content and other analytical parameters should be considered separately from the nominal quantity.
Analytical Testing & Batch Documentation
SPX Labs prioritises batch traceability and analytical transparency. Analytical information is associated with the relevant identifiable batch rather than being presented as a universal specification covering every NAD+ research material.
Where applicable, supporting analytical documentation for NAD+ batches will be made available through the SPX Labs COA Library.
Analytical results relate specifically to the sample and batch identified within the applicable documentation and should not be interpreted as a guarantee that every past or future batch will produce identical results.
Where a particular analytical parameter has not been reported by the testing laboratory, SPX Labs does not assign or infer a result for that parameter.
Understanding NAD+ Analytical Information
Analytical assessment of NAD+ research material may involve techniques selected according to the analytical objective, including chromatographic and mass-spectrometric methods where appropriate.
Different analytical measurements describe different characteristics of a research material. A reported content measurement, for example, should not automatically be interpreted as establishing purity or other characteristics that were not specifically assessed.
Similarly, analytical measurements relating to identity, content or purity do not by themselves establish sterility, endotoxin status, pharmaceutical approval, clinical efficacy or suitability for human or veterinary use.
SPX Labs therefore presents analytical information as batch-specific research-material documentation and identifies analytical parameters according to the information actually reported for the applicable sample.
NAD+ Batch Traceability
Each NAD+ research material supplied by SPX Labs carries an identifiable SPX batch reference designed to connect the material with relevant batch information and applicable supporting documentation.
Researchers should retain this reference when reviewing analytical information, using the SPX batch-verification system or contacting SPX Labs regarding a particular product.
The SPX Labs Quality & Testing section explains the approach used for batch identification, analytical documentation and SPX internal research-material quality criteria.
This batch-focused approach helps prevent analytical results from another compound, sample or unrelated batch from being incorrectly attributed to the supplied material.
Scientific Research Context
Nicotinamide adenine dinucleotide (NAD+) is a naturally occurring cellular coenzyme with important roles in biochemical reactions involving cellular energy metabolism and redox processes.
NAD+ exists alongside its reduced form, NADH, as part of a redox pair involved in the transfer of electrons during numerous metabolic reactions. NAD+-dependent biological pathways are consequently studied across areas including cellular metabolism, mitochondrial biology and biochemical signalling.
NAD+ also participates as a substrate for several classes of enzymes involved in cellular regulation. This has contributed to scientific interest in NAD+ metabolism and the mechanisms responsible for maintaining cellular NAD+ availability.
Researchers can consult NAD+ metabolism research indexed by PubMed for peer-reviewed scientific literature concerning NAD+ biology and metabolism.
SPX Labs does not present experimental findings concerning NAD+ as established clinical outcomes or as evidence supporting therapeutic use of the supplied research material.
NAD+ and Cellular Metabolism Research
NAD+ has an established biochemical role in oxidation-reduction reactions involved in cellular metabolism. Research concerning the NAD+/NADH system includes investigation of pathways associated with glycolysis, the citric acid cycle and mitochondrial energy metabolism.
Scientific research also examines the relationship between cellular NAD+ availability and enzymes that utilise NAD+ as a substrate, including sirtuins and poly(ADP-ribose) polymerases (PARPs).
These areas represent biochemical and experimental research contexts and should not be interpreted as claims that the SPX Labs NAD+ research material produces particular physiological or therapeutic outcomes.
Storage & Laboratory Handling
Store the research material in accordance with the storage and handling information supplied with the applicable batch.
Appropriate laboratory procedures should be followed when handling research materials, and unnecessary exposure to adverse environmental conditions should be avoided.
Researchers and laboratories remain responsible for determining appropriate handling, storage and experimental procedures for their particular research environment and intended analytical application.
Frequently Asked Questions
What is NAD+?
NAD+ stands for nicotinamide adenine dinucleotide. It is a naturally occurring coenzyme involved in numerous cellular biochemical processes, particularly oxidation-reduction reactions and cellular metabolism.
Is NAD+ a peptide?
No. NAD+ is a coenzyme rather than a peptide. SPX Labs therefore describes NAD+ as a research compound rather than representing it as a peptide.
How much NAD+ does this product contain?
The nominal SPX Labs presentation contains 500mg of NAD+. Where batch-specific analytical content measurements are available, those results should be considered separately from the nominal product presentation.
Is batch-specific analytical documentation available?
Batch-specific analytical information will be associated with the identifiable SPX batch where applicable. Available documentation can be reviewed through the SPX Labs COA Library.
Why does SPX Labs use batch references?
Batch references help connect a specific research material with the analytical information and supporting documentation applicable to that batch, reducing the risk of results from unrelated samples being incorrectly attributed to the supplied material.
Is NAD+ supplied for human use?
No. SPX Labs supplies NAD+ exclusively for legitimate laboratory research, analytical testing and scientific evaluation. It is not supplied for human or veterinary consumption or administration.
Laboratory Research Notice
NAD+ supplied by SPX Labs is intended strictly for legitimate in-vitro laboratory research, analytical testing and scientific evaluation.
It is not supplied for human or veterinary consumption or administration and is not intended to diagnose, treat, cure or prevent disease.
SPX Labs — Precision Research. Verified Quality.
spxlabs.co.uk | info@SPXLabs.co.uk
